US Patent 7700732 Prekallikrein depleted plasma derived albumin fraction

Patent 7700732 was granted and assigned to Octapharma on April, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Octapharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7700732

Date of Patent

April 20, 2010

Patent Application Number

10533160

Date Filed

November 25, 2003

Patent Primary Examiner

‌

Karen Cochrane Carlson

Patent abstract

An albumin containing fraction having a reduced prekallikrein activator (PKA) content and a method of manufacturing same comprising the steps of:(a) reconstitution of paste V (Cohn fractionation),(b) performing a concentration step of the fraction obtained in step (a),(c) heating the fraction obtained in step (b) in a range of from 50° C. to 70° C. for a sufficient time to pasteurize the fraction, and(d) optionally filling of the obtained fraction for use.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7700732 Prekallikrein depleted plasma derived albumin fraction

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API